Rotech Healthcare

eXciteOSA®

eXciteOSA®

eXciteOSA®

eXciteOSA held in hand from side

eXciteOSA®

Finally, a mask-free solution for mild sleep apnea and snoring

eXciteOSA® is a small mouthpiece you wear for just 20 minutes during the day. It gently trains your tongue muscle so your airway stays open at night — and you (and your partner) finally sleep.

  • Works while you’re awake — use it anytime during the day
  • Clinically proven to reduce snoring and mild OSA
  • FSA & HSA compatible

90%

of patients reported reduced snoring

79%

of mild OSA patients responded to eXciteOSA therapy

52%

average reduction in AHI after therapy

6 Weeks

to see results with just 20 minutes/day

How eXciteOSA® works

Mild OSA happens when tongue muscle loses tone and collapses the airway during sleep. eXciteOSA trains it back, during the day.

A middle-aged couple in bathrobes standing in a bright, modern kitchen. The man holds an eXciteOSA device while the woman smiles and holds a coffee mug, suggesting a relaxed morning routine.

stimulation builds strength

Gentle electrical pulses through flexible silicone electrodes on your tongue — you'll feel mild contractions, nothing painful.

Four 5-minute phases per session

Each phase targets tongue muscle at a different frequency.

Stronger muscles, open airway

Improved muscle tone prevents the tongue from collapsing backward during sleep, reducing apnea events and snoring.

App tracks every session

The eXciteOSA app connects via Bluetooth, adjusts intensity levels, and helps you monitor your progress

Patient Profiles*

eXciteOSA is especially well-suited for patients who’ve struggled with PAP therapy and compliance, or who’ve avoided treatment altogether.

Hated her CPAP mask

Anne, 48

Registered nurse with two kids who wasn’t adhering to her APAP therapy.

“I could wear it while spending time with my kids at home. I’m happier, have more energy, and get through the day and evening with no struggles.”

Sleeping better after 6 weeks

Photo of hypothetical patient Jamie G
Stopped using CPAP entirely

Jamie, 52

Busy executive who felt claustrophobic in the mask and kept ripping it off overnight.

“I feel more relaxed, my concentration has increased, and I have energy into the evening hours. The device was easy to wear at the office.”

No longer needs CPAP

Never filled his prescription

Trey, 37

Truck driver whose snoring was straining his marriage, but wouldn’t sleep in a mask.

“I didn’t have to wear an unattractive device at night. My snoring reduced significantly and my wife and I are both happy.”

Snoring significantly reduced

*hypothetical patients

frequently asked questions

Snoring is caused by vibration of the structures of the throat during sleep. When you sleep, the muscles of the upper airway and tongue relax and partially collapse. The narrowest parts of the throat can then create turbulence in the air flowing through your upper airway as you exhale – creating the snoring sound.
You’re more likely to snore if you:

  • Are overweight
  • Smoke
  • Drink too much alcohol
  • Sleep on your back

While snoring itself is not detrimental to your health, research shows that snoring affects the sleep quality of the snorer and the bed partner. It also may be indicative of a more serious condition called mild obstructive sleep apnea (OSA). Mild OSA is a serious health condition associated with other health problems, such as high blood pressure and increased risks of heart attack, stroke, or death.

eXciteOSA improves the muscle function in the tongue through stimulation therapy. Improvement of muscle function prevents the tongue from collapsing backwards and trains the upper airway to remain open during sleep, thereby improving sleep quality.

Multiple clinical studies have tested the effectiveness of eXciteOSA therapy and have observed statistically significant reductions in both mild obstructive sleep apnea and snoring measurements. In a group of 65 mild OSA patients, 79% noticed a notable reduction in three different mild OSA measurements (AHI, ODI, and ESS Score). In a group of 115 snoring patients, 90% demonstrated an objective snoring reduction of 46%.

Additional ongoing clinical trials in the US will be completed in the near future.

Your eXciteOSA device should be worn for twenty minutes a day, one time each day, for six weeks, and only twice per week thereafter.


Each session includes four, 5-minute simulation therapy phases.


Some patients experience a slight accumulation of saliva, but this sensation will likely go away after a few therapy sessions.

You will not be eligible for eXciteOSA therapy if you…

  • are pregnant or may become pregnant.
  • have a pacemaker, or an implanted electrode.
  • have dental jewelry in the mouth.
  • are suffering from mouth ulcers.
  • have or are suspected of having an AHI ≥ 15 as determined by evaluation by a Sleep Health Professional with a sleep study.

Clinical trials did not include patients with a BMI over 35, so it is not known if the eXciteOSA® therapy will be effective in patients with a BMI above 35.

  • Control unit
  • Mouthpiece
  • USB charging cable
  • USB extender cable
  • Quick Start Guide

Therapy sessions are 20 minutes long, are completed 1 time each day, for 6 weeks. A minimum of two 20-minute sessions are required each week thereafter. Failure to complete the therapy sessions following the 6-week period may result in a return of your mild obstructive sleep apnea and/or snoring symptoms. Consistency is key!

Most users notice improvements in as soon as 6 weeks. Efficacy is dependent upon adherence to the recommended therapy program of 20-minute sessions, completed 1 time each day, for 6 weeks.

Ready to sleep better?

Order online, call our team, or email us — we’re here to help you get started.

Order Online

Order online from ShopRotech.com

866-768-3244

Mon-Fri, 8 a.m.–5 p.m. CT

Get more information from exciteosaretail@rotech.com

references

  1. E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52.

  2. A.Sama et al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018.

  3. eXciteOSA® White Paper (2020). Clinical study of 115 patients with snoring or mild OSA (Apnea-Hypopnea Index (AHI) <15 n=65) completed the trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPAT® night sleep studies before and after the use of the device. An intra-oral tongue stimulator device was used for 20 mins, once a day for 6-week period. (Internal publication by SMT for educational purposes and submission.)

For billing questions or insurance updates, click the NEW chat icon in the lower right — we’re here to help!